These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21291406)

  • 1. Evolving therapies and FAK inhibitors for the treatment of cancer.
    Dunn KB; Heffler M; Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):722-34. PubMed ID: 21291406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase as a cancer therapy target.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):735-41. PubMed ID: 21214510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting focal adhesion kinase in cancer-part I.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):713. PubMed ID: 21348852
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting focal adhesion kinase in neuroblastoma.
    Gillory L; Beierle EA
    Anticancer Agents Med Chem; 2010 Dec; 10(10):714-21. PubMed ID: 21269252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of FAK in tumor metabolism and therapy.
    Zhang J; Hochwald SN
    Pharmacol Ther; 2014 May; 142(2):154-63. PubMed ID: 24333503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting FAK in anticancer combination therapies.
    Dawson JC; Serrels A; Stupack DG; Schlaepfer DD; Frame MC
    Nat Rev Cancer; 2021 May; 21(5):313-324. PubMed ID: 33731845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase: a potential target in cancer therapy.
    van Nimwegen MJ; van de Water B
    Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders.
    Yang M; Xiang H; Luo G
    Biochem Pharmacol; 2024 Jun; 224():116246. PubMed ID: 38685282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAK and interacting proteins as therapeutic targets in pancreatic cancer.
    Ucar DA; Hochwald SN
    Anticancer Agents Med Chem; 2010 Dec; 10(10):742-6. PubMed ID: 21235432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
    Pang XJ; Liu XJ; Liu Y; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Jin CY; Zhang SY
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FAK inhibitors in cancer, a patent review - an update on progress.
    Ye YX; Cao YY; Xu LS; Wang HC; Liu XH; Zhu HL
    Expert Opin Ther Pat; 2024 Aug; 34(8):593-610. PubMed ID: 38946486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials.
    Mohanty A; Pharaon RR; Nam A; Salgia S; Kulkarni P; Massarelli E
    Expert Opin Investig Drugs; 2020 Apr; 29(4):399-409. PubMed ID: 32178538
    [No Abstract]   [Full Text] [Related]  

  • 13. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
    Zhou J; Yi Q; Tang L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):250. PubMed ID: 31186061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAK inhibitors in Cancer, a patent review.
    Lv PC; Jiang AQ; Zhang WM; Zhu HL
    Expert Opin Ther Pat; 2018 Feb; 28(2):139-145. PubMed ID: 29210300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.
    Schultze A; Fiedler W
    Anticancer Agents Med Chem; 2011 Sep; 11(7):593-9. PubMed ID: 21787277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
    Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathways: Endothelial Cell FAK-A Target for Cancer Treatment.
    Roy-Luzarraga M; Hodivala-Dilke K
    Clin Cancer Res; 2016 Aug; 22(15):3718-24. PubMed ID: 27262114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal adhesion kinase: a promising target for anticancer therapy.
    Chatzizacharias NA; Kouraklis GP; Theocharis SE
    Expert Opin Ther Targets; 2007 Oct; 11(10):1315-28. PubMed ID: 17907961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
    Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
    Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAK signaling in human cancer as a target for therapeutics.
    Lee BY; Timpson P; Horvath LG; Daly RJ
    Pharmacol Ther; 2015 Feb; 146():132-49. PubMed ID: 25316657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.